Industry: Chemical & Material
Published Date: 2025-08-14
Pages: 92 Pages
Report ld: 3420774
Request Sample
Customized Report
The global market for Neohesperidoside was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Neohesperidoside competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Neohesperidoside is a bioactive compound extracted from natural plants, primarily sourced from the peels of citrus fruits. It possesses various biological activities, including antioxidant, anti-inflammatory, and immune-modulating properties. In the pharmaceutical, food, and cosmetics industries, neohesperidoside has garnered significant attention due to its natural origin and wide-ranging health benefits. As a functional ingredient, it is widely used in health supplements, functional foods, and skincare products to meet the growing consumer demand for natural, healthy, and eco-friendly products. With the increasing global market for natural plant extracts, neohesperidoside holds great market potential and a promising future for research and application.
Market Development Opportunities & Main Driving Factors
The market development opportunities for neohesperidoside are primarily driven by the growing consumer demand for natural and healthy products. As awareness of health issues continues to rise, the application of natural plant extracts in the pharmaceutical, food, and cosmetics industries is expanding. Neohesperidoside, with its multiple bioactive properties, can meet the consumer demand for safe and healthy products. Additionally, the increasing global demand for functional foods and health supplements has propelled the use of neohesperidoside in these areas. Its antioxidant and anti-inflammatory properties make it an ideal health ingredient for developing products that prevent chronic diseases. Meanwhile, the rapid development of emerging markets also provides vast opportunities for the market expansion of neohesperidoside.
Market Challenges, Risks, & Restraints
Despite the promising market outlook for neohesperidoside, it also faces several challenges and risks. Firstly, its extraction process is relatively complex and costly, which may limit its large-scale production and application. Moreover, the market competition is fierce, with numerous similar natural plant extracts available. Neohesperidoside needs to differentiate itself in terms of product quality and functionality. The strictness of regulations and standards is another challenge, as different countries and regions have varying regulatory requirements for natural plant extracts. Companies need to ensure their products comply with relevant regulations to avoid market access barriers. Lastly, consumer awareness and acceptance of natural products vary, and some may question the efficacy and safety of neohesperidoside, necessitating stronger market education and brand building by companies.
Downstream Demand Trends
The downstream demand trends for neohesperidoside are characterized by diversification and high-end application. In the pharmaceutical sector, its antioxidant and anti-inflammatory properties make it a key ingredient for developing new drugs and health supplements. With increasing attention to the prevention of chronic diseases, the application of neohesperidoside in products for cardiovascular diseases, diabetes, and inflammation-related conditions is set to grow. In the food industry, the demand for functional foods drives the use of neohesperidoside in beverages, health supplements, and nutritional additives. Its natural origin and health benefits make it an ideal food ingredient. In the cosmetics field, its antioxidant properties offer broad prospects for anti-aging and skincare products. As consumer demand for natural skincare products rises, the application of neohesperidoside in high-end skincare products is expected to expand.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Neohesperidoside, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neohesperidoside.
The Neohesperidoside market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neohesperidoside market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neohesperidoside manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Biospringer
BASF SE
Cargill
Chr.Hansen Holding A/S
Corbion NV
CP Kelco
DowDuPont
Edlong Dairy Technologies
Firmenich SA
FMC Health and Nutrition
Segment by Type
Food Grade
Industrial Grade
Pharmacy Grade
Segment by Application
Food
Cosmetics
Medicine
Production by Region
North America
Europe
China
Japan
India
Southeast Asia
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neohesperidoside manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Neohesperidoside by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Neohesperidoside in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Neohesperidoside Market Overview
1.1 Product Definition
1.2 Neohesperidoside by Type
1.2.1 Global Neohesperidoside Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Food Grade
1.2.3 Industrial Grade
1.2.4 Pharmacy Grade
1.3 Neohesperidoside by Application
1.3.1 Global Neohesperidoside Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Food
1.3.3 Cosmetics
1.3.4 Medicine
1.4 Global Market Growth Prospects
1.4.1 Global Neohesperidoside Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Neohesperidoside Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Neohesperidoside Production Estimates and Forecasts (2020-2031)
1.4.4 Global Neohesperidoside Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Neohesperidoside Production Market Share by Manufacturers (2020-2025)
2.2 Global Neohesperidoside Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Neohesperidoside, Industry Ranking, 2023 VS 2024
2.4 Global Neohesperidoside Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Neohesperidoside Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Neohesperidoside, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Neohesperidoside, Product Offered and Application
2.8 Global Key Manufacturers of Neohesperidoside, Date of Enter into This Industry
2.9 Neohesperidoside Market Competitive Situation and Trends
2.9.1 Neohesperidoside Market Concentration Rate
2.9.2 Global 5 and 10 Largest Neohesperidoside Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Neohesperidoside Production by Region
3.1 Global Neohesperidoside Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Neohesperidoside Production Value by Region (2020-2031)
3.2.1 Global Neohesperidoside Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Neohesperidoside by Region (2026-2031)
3.3 Global Neohesperidoside Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Neohesperidoside Production Volume by Region (2020-2031)
3.4.1 Global Neohesperidoside Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Neohesperidoside by Region (2026-2031)
3.5 Global Neohesperidoside Market Price Analysis by Region (2020-2025)
3.6 Global Neohesperidoside Production and Value, Year-over-Year Growth
3.6.1 North America Neohesperidoside Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Neohesperidoside Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Neohesperidoside Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Neohesperidoside Production Value Estimates and Forecasts (2020-2031)
3.6.5 India Neohesperidoside Production Value Estimates and Forecasts (2020-2031)
3.6.6 Southeast Asia Neohesperidoside Production Value Estimates and Forecasts (2020-2031)
4 Neohesperidoside Consumption by Region
4.1 Global Neohesperidoside Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Neohesperidoside Consumption by Region (2020-2031)
4.2.1 Global Neohesperidoside Consumption by Region (2020-2025)
4.2.2 Global Neohesperidoside Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Neohesperidoside Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Neohesperidoside Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Neohesperidoside Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Neohesperidoside Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Neohesperidoside Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Neohesperidoside Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Neohesperidoside Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Neohesperidoside Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Neohesperidoside Production by Type (2020-2031)
5.1.1 Global Neohesperidoside Production by Type (2020-2025)
5.1.2 Global Neohesperidoside Production by Type (2026-2031)
5.1.3 Global Neohesperidoside Production Market Share by Type (2020-2031)
5.2 Global Neohesperidoside Production Value by Type (2020-2031)
5.2.1 Global Neohesperidoside Production Value by Type (2020-2025)
5.2.2 Global Neohesperidoside Production Value by Type (2026-2031)
5.2.3 Global Neohesperidoside Production Value Market Share by Type (2020-2031)
5.3 Global Neohesperidoside Price by Type (2020-2031)
6 Segment by Application
6.1 Global Neohesperidoside Production by Application (2020-2031)
6.1.1 Global Neohesperidoside Production by Application (2020-2025)
6.1.2 Global Neohesperidoside Production by Application (2026-2031)
6.1.3 Global Neohesperidoside Production Market Share by Application (2020-2031)
6.2 Global Neohesperidoside Production Value by Application (2020-2031)
6.2.1 Global Neohesperidoside Production Value by Application (2020-2025)
6.2.2 Global Neohesperidoside Production Value by Application (2026-2031)
6.2.3 Global Neohesperidoside Production Value Market Share by Application (2020-2031)
6.3 Global Neohesperidoside Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Biospringer
7.1.1 Biospringer Neohesperidoside Company Information
7.1.2 Biospringer Neohesperidoside Product Portfolio
7.1.3 Biospringer Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Biospringer Main Business and Markets Served
7.1.5 Biospringer Recent Developments/Updates
7.2 BASF SE
7.2.1 BASF SE Neohesperidoside Company Information
7.2.2 BASF SE Neohesperidoside Product Portfolio
7.2.3 BASF SE Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.2.4 BASF SE Main Business and Markets Served
7.2.5 BASF SE Recent Developments/Updates
7.3 Cargill
7.3.1 Cargill Neohesperidoside Company Information
7.3.2 Cargill Neohesperidoside Product Portfolio
7.3.3 Cargill Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Cargill Main Business and Markets Served
7.3.5 Cargill Recent Developments/Updates
7.4 Chr.Hansen Holding A/S
7.4.1 Chr.Hansen Holding A/S Neohesperidoside Company Information
7.4.2 Chr.Hansen Holding A/S Neohesperidoside Product Portfolio
7.4.3 Chr.Hansen Holding A/S Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Chr.Hansen Holding A/S Main Business and Markets Served
7.4.5 Chr.Hansen Holding A/S Recent Developments/Updates
7.5 Corbion NV
7.5.1 Corbion NV Neohesperidoside Company Information
7.5.2 Corbion NV Neohesperidoside Product Portfolio
7.5.3 Corbion NV Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Corbion NV Main Business and Markets Served
7.5.5 Corbion NV Recent Developments/Updates
7.6 CP Kelco
7.6.1 CP Kelco Neohesperidoside Company Information
7.6.2 CP Kelco Neohesperidoside Product Portfolio
7.6.3 CP Kelco Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.6.4 CP Kelco Main Business and Markets Served
7.6.5 CP Kelco Recent Developments/Updates
7.7 DowDuPont
7.7.1 DowDuPont Neohesperidoside Company Information
7.7.2 DowDuPont Neohesperidoside Product Portfolio
7.7.3 DowDuPont Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.7.4 DowDuPont Main Business and Markets Served
7.7.5 DowDuPont Recent Developments/Updates
7.8 Edlong Dairy Technologies
7.8.1 Edlong Dairy Technologies Neohesperidoside Company Information
7.8.2 Edlong Dairy Technologies Neohesperidoside Product Portfolio
7.8.3 Edlong Dairy Technologies Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Edlong Dairy Technologies Main Business and Markets Served
7.8.5 Edlong Dairy Technologies Recent Developments/Updates
7.9 Firmenich SA
7.9.1 Firmenich SA Neohesperidoside Company Information
7.9.2 Firmenich SA Neohesperidoside Product Portfolio
7.9.3 Firmenich SA Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Firmenich SA Main Business and Markets Served
7.9.5 Firmenich SA Recent Developments/Updates
7.10 FMC Health and Nutrition
7.10.1 FMC Health and Nutrition Neohesperidoside Company Information
7.10.2 FMC Health and Nutrition Neohesperidoside Product Portfolio
7.10.3 FMC Health and Nutrition Neohesperidoside Production, Value, Price and Gross Margin (2020-2025)
7.10.4 FMC Health and Nutrition Main Business and Markets Served
7.10.5 FMC Health and Nutrition Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Neohesperidoside Industry Chain Analysis
8.2 Neohesperidoside Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Neohesperidoside Production Mode & Process Analysis
8.4 Neohesperidoside Sales and Marketing
8.4.1 Neohesperidoside Sales Channels
8.4.2 Neohesperidoside Distributors
8.5 Neohesperidoside Customer Analysis
9 Neohesperidoside Market Dynamics
9.1 Neohesperidoside Industry Trends
9.2 Neohesperidoside Market Drivers
9.3 Neohesperidoside Market Challenges
9.4 Neohesperidoside Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Neohesperidoside market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 78
USD 4250.00
(Single User License)
The global Neohesperidoside market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 133
USD 4900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 3950.00
(Single User License)
The global Neohesperidoside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 129
USD 2900.00
(Single User License)
The global Neohesperidoside market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 145
USD 4900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-14
Pages: 102
USD 3950.00
(Single User License)
The global Neohesperidoside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-14
Pages: 80
USD 4250.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 97
USD 3950.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 126
USD 3950.00
(Single User License)
The global Neohesperidoside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 95
USD 2900.00
(Single User License)
The global Neohesperidoside market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 78
The global Neohesperidoside market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 133
The global market for Neohesperidoside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 108
The global Neohesperidoside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 129
The global Neohesperidoside market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 145
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-14
Pages: 102
The global Neohesperidoside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-14
Pages: 80
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 97
The global market for Neohesperidoside was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 126
The global Neohesperidoside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now